Get the app
US › Healthcare

Allurion Technologies, Inc. (ALUR)

US · Healthcare · Medical Devices

$0.470.00%
Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue
$2.9M
Revenue YoY
-47.2%
Net profit
$-6.1M
EPS
$-6.90
EPS estimate
$-5.10
Net margin
-206.8%

EPS came in at -6.90 against a street estimate of -5.10 — a miss of 35.3%.

Key statistics

Market cap
$342,107
Forward P/E
1.0
P/B
0.00
Book value
$-77.94
EPS (TTM)
$-54.75
52-week high
$8.52
52-week low
$0.23
50-day MA
$1.86
200-day MA
$1.77
Beta
-0.13

Analyst view

with an average price target of $82.50.

Shareholding

Insiders
5.18%
Institutions
7.90%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Allurion Technologies, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.